The Japan Drug Information Institute in Pregnancy
Data collection and consultations are being implemented since the October of 2010 for the Ministry of Health, Labor and Welfare project, “The effect of medication on pregnant women and fetus.” Currently in Japan, we cannot say there is sufficient information concerning the effect of medication on pregnant women and the fetus. As for the consultation, accumulated data from pediatric hospitals and existing literature are utilized as general information by collaborating with the University of Toronto (Canada), striving to protect pregnant women and fetus from the effects of medication beforehand by providing scientifically evaluated medication information to pregnant mothers and those interested in pregnancy.
This center is also independently collaborating with pregnant women to survey and collect information on the effects of the medication to create a database for each medication.
We are planning to designate “cooperating hospitals” nationwide and operate a two-way communication network for providing information to anyone consulting in the near future.
History of JDIIP
|Year||Area of Consultation||Number of Consultations|
|2005||Setagaya, Tokyo||111 Cases|
|2006||Expanded area of consultation to metropolitan area (One capital, six prefectures).
*Starting September 2006
|2007||Area of consultation expanded nationwide, established three core hospitals.||673 Cases|
|2008||Expanded to 9 core hospitals.||960 Cases|
|2009||Expanded to 12 core hospitals.||1016 Cases|
|2010||Expanded to 14 core hospitals.||1092 Cases|
|2011||Expanded to 18 core hospitals.||1096 Cases|
|2012||Expanded to 21 core hospitals.||2385 Cases|
|2013||Expanded to 24 core hospitals.||2088 Cases|
|2014||Expanded to 28 core hospitals.||2205 Cases|
|2015||Expanded to 33 core hospitals.||2075 Cases|
|2016||Expanded to 38 core hospitals.|
|2017||Expanded to 46 core hospitals.|